Sanofi's Acomplia drug helps in diabetes -study

LONDON (Reuters) - Sanofi-Aventis SA's drug Acomplia can significantly improve blood sugar control in patients with type 2 diabetes who are not adequately controlled with insulin therapy, the French drugmaker said on Tuesday.

Continue to Sanofi's Acomplia drug helps in diabetes -study on Reuters Health eLine.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz